glimepiride has been researched along with sildenafil citrate in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Bakal, RL; Chandewar, AV; Dewani, AP; Mazumder, PM; Shelke, PG; Tripathi, AS | 1 |
| Chandewar, AV; Mazumder, PM; Tripathi, AS | 1 |
| Chandewar, A; Mazumder, PM; Timiri, AK; Tripathi, AS | 1 |
4 other study(ies) available for glimepiride and sildenafil citrate
| Article | Year |
|---|---|
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Development and validation of RP-HPLC method for simultaneous estimation of glimepiride and sildenafil citrate in rat plasma-application to pharmacokinetic studies.
Topics: Animals; Chromatography, High Pressure Liquid; Male; Piperazines; Purines; Rats; Rats, Sprague-Dawley; Sildenafil Citrate; Sulfones; Sulfonylurea Compounds | 2013 |
Sildenafil, a phosphodiesterase type 5 inhibitor, attenuates diabetic nephropathy in STZ-induced diabetic rats.
Topics: Animals; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Kidney Function Tests; Male; Phosphodiesterase 5 Inhibitors; Podocytes; Rats; Rats, Sprague-Dawley; Sildenafil Citrate; Streptozocin; Sulfonylurea Compounds; Triglycerides | 2016 |
Does glimepiride alter the pharmacokinetics of sildenafil citrate in diabetic nephropathy animals: investigating mechanism of interaction by molecular modeling studies.
Topics: Animals; Blood Glucose; Cytochrome P-450 CYP2C9; Diabetic Nephropathies; Disease Models, Animal; Drug Interactions; Hypoglycemic Agents; Kidney Function Tests; Models, Molecular; Molecular Docking Simulation; Molecular Dynamics Simulation; Molecular Structure; Phosphodiesterase 5 Inhibitors; Protein Conformation; Rats; Serum Albumin; Sildenafil Citrate; Structure-Activity Relationship; Sulfonylurea Compounds | 2015 |